Results of CPhI 2014: Novalik-Pharm and Pharmplanet presented a unique immunomodulator Beta-Immun

KYIV, Ukraine - Oct. 15, 2014 - PRLog -- On October 7-9, Ukrainian pharmaceutical company Novalik-Pharm and its official distributor Pharmplanet took part in the international exhibition in Paris. This year, CPhI Worldwide celebrates its 25th anniversary. Specifically to this date the organizers arranged a competition «Top 25 Success Stories». According to the decision of the jury, Pharmplanet was included in the list of 25 most successful pharmaceutical world's companies for most dynamic development of the market.

Following the negotiations, Novalik-Pharm and Pharmplanet made contacts with three dozen of foreign companies, some of them are interested in our new developments. Four agreements on contract manufacturing of modern drugs under our trademark with major European and Asian manufacturers were coordinated and prepared for signing. The work executed on long-term projects for the supply of substances for exclusive distribution and contract manufacturing in demand on Ukrainian pharmaceutical market - new generation antibiotics, antivirals, gastroenterology and oncology drugs in new dosage forms, as well as medical products.

– One of the important outcomes was the beginning of cooperation with major Malaysian pharmaceutical company on contract manufacturing modern medicines, – says Nataliya Sergeyko, Head of Novalik-Pharm. – One of them is hormonal preparation of a new generation which is 30 times more effective but less toxic than hydrocortisone by the level of anti-inflammatory activity, and don’t possesses mineralocorticoid activity. All the products that company presents to its consumers around the world are manufactured by three pharmaceutical factories, equipped in touch with the state-of-the-art in the field in accordance with the requirements of Good Manufacturing Practice (GMP). A significant part of the products approved by FDA (Food&Drug Administration, USA) and exported to the American market.

Business relationships established with the Taiwanese company on contract manufacturing line of modern antibiotics, unique patches for the treatment of joints and spine diseases, as well as original dressings for wound healing.

As announced earlier, Novalik-Pharm presented to the international community jointly developed with Austrian experts, innovative product Beta-Immun – natural immunomodulator with anti-inflammatory action on the basis of beta-glucans. The drug has a special composition of immunotrophic substance that causes a powerful impact on all parts of the immune system, effectively reduces the severity of inflammation. Beta-Immun aroused a great interest among the European partners. So that companies from Poland and Italy having considered the benefit of the drug decided to explore the possibility of its registration and distribution in the European Union.

In addition to Beta-Immun, European and Asian partners were interested in other original developments of Novalik-Pharm: DryVir for the treatment of herpes, a new combined veinotonic Venoda with a more powerful vienotropic action, natural hepatoprotector Hepanaze with anti-inflammatory and regenerative properties and others. Therefore, in the near future, the appearance of Novalik-Pharm products is expected not only in Ukraine and the CIS countries, but also in the market of Europe and Southeast Asia.

Participation of Ukrainian pharmaceutical companies in the large-scale international exhibitions is further evidence of the active development of the domestic pharmaceutical industry. New knowledge acquired at such events, allow introducing modern world technology that is a key to the creation of improved medicines, and new contacts can develop into strong partnerships.

CPhI Worldwide 2014 (http://www.cphi.com/) is the world's leading pharmaceutical networking event, which already 25 years combines all stages of research, development and manufacture of pharmaceutical products and their raw materials. Exhibition hosted over 2,200 exhibitors and 34,000 attendees and from 140 countries.

Pharmplanet (http://www.pharmplanet.com.ua/en/) is an expert at the pharmaceutical market, one of the industry leaders, a national service pharmaceutical company, offering a full range of services in the following areas: registration and distribution of pharmaceutical products, medical devices, cosmetics and biologically active supplements. It ranks among Top 5 leaders – the distributors of the pharmaceutical market of Ukraine. We possess 20 years of experience in developing and delivering innovative products and effective solutions aimed at preserving and improving the health of the nation. Among the partners of the company there are more than 300 major manufacturers. The Pharmplanet promotes its own brands: Sitoprostat, Hepanaze, Deklimans, Silenor, Apiproposol as well as it is the official distributor of the foreign producers: Alflutop, Karminativum Bebinos, Dentinox-Gel N, Mikogynaks, Galavit, Folio, Neokaripazim-400, Infasurf, Arpeflu, GeloMyrtol, GeloMyrtol Forte, oxygen water Vitaoxy V, skincare products Sebamed.

Novalik-Pharm (http://www.novalik.com/) is a modern pharmaceutical enterprise specialized in developing and manufacturing innovative and reasonable for consumers pharmaceutical products at the same time: medicinal products, biologically active supplements, cosmetics and hygiene products. In the field of pharmaceutical product manufacturing Novalik-Pharm uses the latest scientific developments in the field of pharmacy and medicine, experience of the world leaders in pharmaceutical industry and modern technologies, as well as  high-quality standardized extracts and substances mostly imported from the European companies. Novalik-Pharm manufactures and promotes DryVir, Tribustim, Venoda.